PharmaMaxx
Retatrutide 15 mg, 20 mg, 30 mg product presentationFor research use only

PharmaMaxx / Weight Loss & Metabolism

Retatrutide

30 mg

Available variants

The current catalog image represents the 30 mg presentation.

A triple GLP-1, GIP and glucagon receptor agonist studied in metabolic models.

Format
Lyophilized powder
Strength
30 mg
Storage & distribution
Handled entirely by PharmaMaxx
Category
Weight Loss & Metabolism
Order via WhatsApp

For research use only. Product information is provided for informational and laboratory research purposes.

Product dossier

Technical information organized for quick review.

01 / Summary

Overview

A concise product-specific introduction followed by the essential catalog profile.

Retatrutide is an experimental peptide that acts on the GLP-1, GIP and glucagon receptor pathways. It is investigated in research models involving appetite regulation, glycemic control and body composition.

Category
Weight Loss & Metabolism
Presentation
Lyophilized powder
Available strengths
15 mg, 20 mg, 30 mg

02 / Specifications

Product Information

Identity, presentation and technical reference details for this specific catalog item.

01

Identity & classification

Product
Retatrutide
Catalog
PharmaMaxx
Classification
Weight Loss & Metabolism
02

Presentation

Dosage form
Lyophilized powder
Variants
15 mg, 20 mg, 30 mg
03

Technical reference

Storage & distribution
Handled entirely by PharmaMaxx

Storage & Distribution

Storage and distribution are handled entirely by PharmaMaxx.

Related portfolio

More in Weight Loss & Metabolism